Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $671000.0.

  • Rhythm Pharmaceuticals' Other Non-Current Assets rose 4523.81% to $671000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $671000.0, marking a year-over-year increase of 4523.81%. This contributed to the annual value of $464000.0 for FY2024, which is 4146.34% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Other Non-Current Assets of $671000.0 as of Q3 2025, which was up 4523.81% from $527000.0 recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $671000.0 during Q3 2025, with a 5-year trough of $328000.0 in Q1 2021.
  • Over the past 5 years, Rhythm Pharmaceuticals' median Other Non-Current Assets value was $328000.0 (recorded in 2021), while the average stood at $391789.5.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 1861.04% in 2021, then surged by 4523.81% in 2025.
  • Rhythm Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $328000.0 in 2021, then changed by 0.0% to $328000.0 in 2022, then changed by 0.0% to $328000.0 in 2023, then soared by 41.46% to $464000.0 in 2024, then soared by 44.61% to $671000.0 in 2025.
  • Its Other Non-Current Assets was $671000.0 in Q3 2025, compared to $527000.0 in Q2 2025 and $464000.0 in Q1 2025.